Last year, Israel overtook Germany as the largest importer of medical cannabis, and this is a market that we are bullish on. One of the reasons we are excited about the Israeli cannabis market is related to the economics that is associated with the cultivation process. In Israel, the cost per gram of cannabis is considerably lower than in Canada. The reason why it costs less to cultivate cannabis in Israel than in Canada is related to the climate, and we consider this to be an important aspect of the market. During the last few years, we have seen an uptick in the number of Canadian Licensed Producers (LPs) that are levered to the Israeli cannabis market. This trend has played an important role in how the Israeli cannabis market has grown and we expect to see total production capacity steadily increase on a year-over-year basis. Read more about various Cannabis operators working with Israel to see how Israel is a key to international outreach.

420 Intel – Marijuana Industry News, 07/11/2021 20:00:00

Open article: